DepoMed (DEPO) Price Target Raised to $22 at Janney
Tweet Send to a Friend
Janney Capital maintained a Buy rating on DepoMed Inc (NASDAQ: DEPO) and raised its price target to $22.00 (from $18.50) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
